Comments
Commented by André Will-Laudien on November 4th, 2021 | 15:10 CET
Varta, Manganese X Energy, Standard Lithium: Battle for the best battery!
Just after the general elections, it was back - the battery fantasy! Whatever the outcome of the formation of the government, all parties involved have shown a high level of commitment to sometimes drastic steps towards climate protection. Electromobility is becoming increasingly crucial for the energy transition in transport. And with it, the research, development and production of drives, batteries and components. In this context, suppliers of battery raw materials and product developers are enjoying a great deal of attention. The triumphant march of Tesla shares continues to pull on the entire sector. Which stocks are ahead?
Read
Commented by Carsten Mainitz on November 4th, 2021 | 11:36 CET
Barsele Minerals, Mutares, Aurelius - Investments create value!
Clever investment strategies can save some ailing companies or turn others into true high-flyers. Investment companies have professionalized these processes and create substantial added value for their investors with sophisticated strategies and portfolios. For this reason, we take a closer look at the topic of acquisitions.
Read
Commented by Stefan Feulner on November 4th, 2021 | 10:33 CET
BMW, Triumph Gold, Klöckner & Co - It is getting more and more expensive
The inflation rate in the eurozone recently rose to 3.4%, the highest level since 2008. Everything is getting more expensive, but the situation is manageable for ECB President Christine Lagarde. Driven by special factors such as the high price of oil and gas and production bottlenecks, prices are skyrocketing. However, an interest rate hike to curb inflation is not on the agenda before 2023, she said. Meanwhile, many listed companies are delivering record figures, benefiting from commodity price increases.
Read
Commented by Stefan Feulner on November 3rd, 2021 | 13:50 CET
Plug Power, Enapter, SFC Energy - The hydrogen sector is alive
Last year, a strong boom was followed by a harsh correction, which brought even market leaders to their knees with share price losses of over 50%. That hydrogen technology is enormously important for achieving climate goals should be beyond question, even at the current World Climate Conference in Glasgow. The segment has a golden future with regard to the energy transition. Position yourself now and invest in the sector with disproportionately high potential.
Read
Commented by André Will-Laudien on November 3rd, 2021 | 13:26 CET
CureVac, Ayurcann, Novavax, NanoRepro: Things are going through the roof here!
Healing and well-being are the focus of many biotech and pharmaceutical companies. In many cases, long research is carried out in order to get corresponding active substances on the way. After many clinical test series, the laborious approval process with the corresponding health authorities then begins. Some companies have provided themselves with good growth capital thanks to the high liquidity on the stock markets and are at the cutting edge with their products. We take a closer look at the industry.
Read
Commented by André Will-Laudien on November 3rd, 2021 | 12:49 CET
Royal Dutch, BP, Saturn Oil + Gas: OPEC sends oil to 100 dollars!
The oil rally continues! In October, the Brent and WTI grades recorded an increase of around 10%. Market observers justified the friendly month with the good mood on the stock markets. The risk appetite returned due to the turn of the markets at the beginning of October. More volatile asset classes such as commodities benefited from this. Time and again, reference is also made to fuel reserves in China, which had recently fallen sharply. The world's second-largest economy could now buy more on the oil market to strategically replenish its reserves. Tension is rising in the oil market. Which stocks can benefit in this environment?
Read
Commented by Carsten Mainitz on November 3rd, 2021 | 12:34 CET
Royal Helium, dynaCERT, Gazprom - What is next?
The oil and gas sector has long been a popular investment area. However, when it comes to gas, hydrogen company share certificates have been more in the spotlight in recent months. A more exciting and also little-noticed field is the noble gas helium. We take a broad look at the investment stories in the gas sector.
Read
Commented by Carsten Mainitz on November 3rd, 2021 | 12:12 CET
Osino Resources, Barrick, Newmont - Now comes the countermovement!
Inflation has been rising significantly for months. In October, consumer prices in the euro area rose by 4.1% YOY, the highest level in over 13 years. In Germany, the inflation rate even climbed to 4.5%! The last time this happened was in October 1993. Central banks dismiss this as a temporary phenomenon. The head of Deutsche Bank, Christian Sewing, made this clear a few days ago with his statements in the Frankfurter Allgemeine Sonntagszeitung. The manager vigorously contradicts the wishful thinking of a temporary phenomenon and calls on the central banks to act. Given these general conditions and prospects, investors can protect their money in the best possible way by investing in tangible assets such as shares, real estate, commodities, or precious metals.
Read
Commented by Armin Schulz on November 3rd, 2021 | 11:03 CET
MorphoSys, Defence Therapeutics, Formycon - Biotech and pharma offer potential for the portfolio
The pharmaceutical industry alone has annual sales of over EUR 1,000 billion worldwide and helps people overcome their illnesses. Since the Corona pandemic, biotech and pharma companies are even more in the spotlight. If a company manages to develop a blockbuster, big profits also beckon to shareholders. BioNTech is currently a prime example of this, even if the share has consolidated in the meantime. Where there are high profits, there is also a higher risk. The road to the development and approval of a drug is long, and failure is also possible. As people are getting older and diseases are rising, it makes sense to invest in these areas. Today we analyze three potential candidates.
Read
Commented by Stefan Feulner on November 3rd, 2021 | 10:16 CET
Valneva, Cardiol Therapeutics, BioNTech - Is the vaccination subscription coming?
The numbers of people infected with Corona have been rising significantly again for weeks. While only about 67% of Germans are fully vaccinated, the pace is slowing noticeably. Meanwhile, the third dose, the so-called "booster" vaccination, has already been started. The Standing Commission on Vaccination (STIKO) has recommended this booster for people aged 70 and over. A decision on whether booster vaccinations should be offered to everyone is likely to be made soon. For vaccine manufacturers, this means recurring revenues.
Read